Rumina Georgieva is a Business Development Executive at Life Science Networks Tell us about your background and how you came to join our company? I’m originally from Sofia, Bulgaria, but I always wanted to study and work in an international
Neel Rawat is Business Development Executive at Life Science Networks Can you tell us a little about your background and how you came to join our company? Neel has a robust background in the event industry, with experience in Aerospace
Shreya Bhattacharjee is a Buisness Development Executive at Life Science Networks Can you tell us a little about your background and how you came to join our company? I am Shreya Bhattacharjee, who is originally from West Bengal.” I have
Luke Bilton is Co-Founder at Life Science Networks Tell us about your background and how you came to launch our company? Before starting Life Science Networks, I spent over 20 years in events and media, with a significant portion in
Pace Life Sciences, LLC, a contract development, and manufacturing organization (CDMO) has announced its acquisition of Catalent’s Center of Excellence for Small Molecule Analytical Services located in Research Triangle Park (RTP), North Carolina. The acquisition is part of Pace’s ongoing
Abzena, a global CDMO specialising in complex biologics and bioconjugates, has introduced its enhanced mammalian cell line development platform, AbZelectPRO, as a standard offering for all customers. The platform now significantly reduces development timelines by more than 30%, enabling biopharma
Evotec has announced a strategic partnership with Novo Nordisk to advance the development of stem cell-based therapies. The collaboration focuses on creating next-generation off-the-shelf cell therapy products for clinical use, with the potential for commercialisation in the future. The agreement
Firelli Alonso, former Senior Director of External Manufacturing at Pfizer, brings over two decades of experience in the pharmaceutical industry. With a PhD in molecular virology, she has spearheaded viral vaccine development and headed Pfizer’s pre-commercial outsourcing group, focusing on
Thermo Fisher Scientific has announced a $22-million investment across its Cincinnati, Ohio, and Bend, Oregon facilities to expand their oral solid dose (OSD) capabilities. The move, initiated in 2021, aims to enhance the research, development, manufacturing, and testing of OSD
Acumen Pharmaceuticals has announced an extension of its partnership with Lonza to prepare for the future commercial launch of sabirnetug (ACU193), a novel therapeutic targeting Alzheimer’s disease (AD). Sabirnetug is the first humanized monoclonal antibody to selectively engage toxic soluble
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
